Avastin Breast Cancer Approval In Spotlight With AVADO
This article was originally published in The Pink Sheet Daily
Executive Summary
CHICAGO - First placebo-controlled, double-blinded evidence for bevacizumab in first-line metastatic breast cancer presented at ASCO.